Menu

Image of the Day: Starved Worm

A heat map of gene expression provides insights on the genes that help C. elegans survive severe caloric restriction.  

Nov 14, 2017
The Scientist Staff, The Scientist Staff

A starved Caenorhabditis elegans worm in an early larval stage, showing the intensity of expression of the gene tps-1, which appears strongest in the intestine and the outer skin  JONATHAN HIBSHMAN & RYAN BAUGH / DUKE UNIVERSITY The nematode worm Caenorhabditis elegans is a popular model to study the physiological reponses that allow animals to cope with starvation. When population densities are high and food is limited, C. elegans will form specialized larval forms—so-called “dauer” larvae—that can survive for months in nutrient-poor conditions, or enter a state of developmental arrest until they feed. To explore the genetics involved in this survival adaptation, scientists took a close look at one gene, known as tps-1, that is involved in synthesizing trehalose, a sugar that helps protect the worms from desiccation and other types of stress. They found that tps-1 expression and trehalose synthesis increases during starvation periods, demonstrating its role as a stress protectant.

See J.D. Hibshman et al., “daf-16/FoxO promotes gluceogenesis and trehalose synthesis during starvation to support survival,” eLife, doi:10.7554/eLife.30057, 2017.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.